Concurrent implantation of sirolimus- and paclitaxel-eluting stents in the same vessel

Catheterization and Cardiovascular Interventions

Volumn 69, Issue 1, 2007, Pages 109-114

  Corbett, Simon J ^a   Cosgrave, John ^a   Colombo, Antonio ^a,b  

^a EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Paclitaxel; Sirolimus; Stent

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FATALITY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; INTERVENTIONAL RADIOLOGY; MALE; TREATMENT OUTCOME;

AGED; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 33845986707     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20913     Document Type: Article

References (31)

1. Teirstein PS. A chicken in every pot and a drug-eluting stent in every lesion. Circulation 2004;109:1906-1910.
2. Mueller T. Stories of Survival and Hope Mark the One Million Patient Milestone for the CYPHER Sirolimus-Eluting Coronary Stent. Miami Lakes, FL: COMTEX; 2005.
3. Boston Scientific Corporation. Boston Scientific announces implantation of millionth TAXUS Express2 coronary stent system. Natick, MA: Boston Scientific Corporation. 2005.
4. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falitico R. RAVEL Study Group. A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780.
5. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Keriakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
6. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptman K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesion. Circulation 2003;108:788-794.
7. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Tift Mann J, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
8. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME, TAXUS V Investigators. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized trial. JAMA 2005;294:1215-1223.
9. Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudku K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Koglin J, Russell ME, TAXUS VI Investigators. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial. Circulation 2005;112:3306-3313.
10. Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi G, Sousa E, Stoll HP for the REALITY trial Investigators. Sirolimus- vs. paclitaxel-eluting stents in de novo coronary artery lesions. The REALITY trial: A randomized controlled trial. JAMA 2006;295:895-904.
11. Windecker S, Remondino A, Eberli F, Juni P, Räber L, Wenaweser P, Togni M, Billinger M, Tüller D, Seiler C, Roffi M, Corti R, Sütsch G, Maier W, Lüscher T, Hess O, Egger M, Meier B. A randomized comparison of a sirolimus with a paclitaxel eluting stent for coronary revascularization. The SIRTAX trial. N Engl J Med 2005;3537:653-662.
12. Dibra A, Kastrati A, Mehilli J, Pache J, Schühlen H, von Beckerath N, Ulm K, Wessely R, Dirschinger J, Schömig A, for the ISAR-DIABETES Study Investigators. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005;353:663-670.
13. Orlic D, Bonizzoni E, Stankovic G, Airoldi F, Chieffo A, Corvaja N, Sangiorgi G, Ferraro M, Briguori C, Montorfano M, Carlino M, Colombo A. Treatment of multi-vessel coronary artery disease with sirolimus-eluting stent implantation: Immediate and mid-term results. J Am Coll Cardiol 2004;43:1154-1160.
14. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Richard AD, Kent KM, Stone GW, Leon MB. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 1999;100:1872-1878.
15. Cosgrave J, Corbett SJ, Babic R, Colombo A. Paclitaxel-eluting stents. Future Cardiol 2006;2:229-239.
16. Marks AR. Sirolimus for the prevention of in-stent restenosis in a coronary artery. N Engl J Med 2003;349:1307-1309.
17. Fajadet J, Morice MC, Bode C, Barragan P, Serruys PW, Wijns W, Constantini CR, Guermonprez JL, Eltchaninoff H, Blanchard D, Bartorelli A, Laarman GJ, Perin M, Sousa JE, Schuler G, Molnar F, Guagliumi G, Colombo A, Ban Hayashi E, Wulfert E. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: Three-year results of the RAVEL trial. Circulation 2005;111:1040-1044.
18. Holmes DR Jr, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ, Brown C, Fischell T, Wong SC, Midei M, Snead D, Kuntz RE. Analysis of 1-year clinical outcomes in the SIRIUS trial. Circulation 2004;109:634-640.
19. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME, the TAXUS-IV Investigators. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation 2004;109:1942-1947.
20. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD. Hypersensitivity cases associated with drug-eluting coronary stents. A review of available cases from the research on adverse drug events and reports (RADAR) project. J Am Coll Cardiol 2006;47:175-181.
21. O'Neill WW, Leon MB. Drug-eluting stents costs versus clinical benefit. Circulation 2003;107:3008-3011.
22. Degertekin M, Serruys PW, Tanabe K, Lee CH, Sousa JE, Colombo A, Morice MC, Ligthart JM, de Feyter PJ. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: An intravascular ultrasound analysis. Circulation 2003;108:2747-2750.
23. Kornowski R, Mehran R, Hong MK, Satler LF, Pichard AD, Kent KM, Mintz GS, Waksman R, Laird JR, Lansky AJ, Bucher TA, Popma JJ, Leon MB. Procedural results and late clinical outcomes after placement of three or more stents in single coronary lesions. Circulation 1998;97:1355-1361.
24. Kornowski R, Mehran R, Satler LF, Pichard AD, Kent KM, Greenberg A, Mintz GS, Hong MK, Leon MB. Procedural results and late clinical outcomes following multivessel coronary stenting. J Am Coll Cardiol 1999;33:420-426.
25. Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo LC, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R. Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 2006;67:595-599.
26. Tsagalou E, Chieffo A, Iakovou I, Ge L, Sangiorgi GM, Corvaja N, Airoldi F, Montorfano M, Michev I, Colombo A. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. J Am Coll Cardiol 2005;45:1570-1573.
27. Cosgrave J, Agostoni P, Ge L, Iakovou I, Chieffo A, Biondi-Zoccai GG, Sangiorgi GM, Montorfano M, Michev I, Airoldi F, Carlino M, Corvaja N, Bonizzoni E, Colombo A. Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions. Am J Cardiol 2005;96:1663-1668.
28. Colombo A, Orlic D, Stankovic G, Corvaja N, Spanos V, Montorfano M, Liistro F, Carlino M, Airoldi F, Chieffo A, di Mario C. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 2003;107:2178-2180.
29. Popma JJ, Leon MB, Moses JW, Holmes DR Jr, Cox N, Fitzpatrick M, Douglas J, Lambert C, Mooney M, Yakubov S, Kuntz RE, for the SIRIUS Investigators. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation 2004;110:3773-3780.
30. Iakovou I, Schmidt T, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Cosgrave J, Gerckens U, Grube E, Colombo A. Angiographic patterns of restenosis after paclitaxel-eluting stent implantation. J Am Coll Cardiol 2005;45:805-806.
31. Minutello RM, Bhagan S, Feldman D, Atul Sharma A, Hong MK, Wong SC. Angiographic pattern of restenosis following implantation of overlapping sirolimus-eluting (cypher) stents. Am J Cardiol 2006;97:499-501.